Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
J Allergy Clin Immunol ; 124(3): 463-70, 470.e1-16, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19733295

ABSTRACT

BACKGROUND: Current treatment strategies for asthma in teenagers derive primarily from information on chronic disease in adults. More detailed understanding of risk factors related to teenage asthma might aid in the development of improved preventive and treatment strategies for this age group. OBJECTIVE: We sought to identify biomarkers associated with asthma phenotypes in teenagers, particularly atopic asthma, and to identify markers that aid in discriminating between atopic subjects at high versus low risk of asthma. METHODS: We studied 1380 unselected 14-year-olds and collected data on clinical history, allergic sensitization, and respiratory and immunoinflammatory function. The latter comprised measurements of circulating inflammatory markers and in vitro innate and adaptive immune functions, including house dust mite T-cell responses. We integrated the data into regression models to identify variables most strongly associated with asthma risk and severity among atopic subjects. RESULTS: Eight hundred twenty-seven subjects were atopic, 140 subjects were asthmatic, and 81% of asthmatic subjects were also atopic. We identified asthma risk variables related to atopy intensity, including specific IgE and eosinophil levels, plus an additional series external to the T(H)2 cascade but that modified risk only in atopic subjects, including IFN-gamma, IL-10, and IL-12 responses and neutrophil numbers in blood. Moreover, bronchial hyperresponsiveness was associated strongly with atopic but not nonatopic asthma, and the bronchial hyperresponsiveness risk profile was itself dominated by atopy-associated variables. CONCLUSIONS: Asthma in teenagers is predominantly driven by atopy acting in concert with a second tier of T(H)2-independent immunoinflammatory mechanisms, which contribute to pathogenesis only against the background of pre-existing inhalant allergy.


Subject(s)
Asthma/epidemiology , Asthma/immunology , Cytokines/immunology , Eosinophils/immunology , Leukocytes, Mononuclear/immunology , Adolescent , Adult , Biomarkers/analysis , Cells, Cultured , Cohort Studies , Cross-Sectional Studies , Cytokines/metabolism , Eosinophils/metabolism , Female , Humans , Immunoglobulin E/blood , Interferon-gamma/immunology , Interferon-gamma/metabolism , Leukocytes, Mononuclear/metabolism , Longitudinal Studies , Male , Multivariate Analysis , Regression Analysis , Severity of Illness Index , Th2 Cells/immunology , Th2 Cells/metabolism
2.
J Allergy Clin Immunol ; 119(5): 1164-73, 2007 May.
Article in English | MEDLINE | ID: mdl-17412403

ABSTRACT

BACKGROUND: The timing of allergen sensitization is controversial, with conflicting evidence suggesting transplacental priming versus exclusively postnatal priming. Resolution of this question is important in relation to rational design of allergy prevention strategies, particularly the issue of allergen avoidance during pregnancy. OBJECTIVE: To elucidate the kinetics of sensitization in high-risk children during their first 2 years of life. METHODS: We prospectively studied house dust mite (HDM)-specific IgE and IgG(4) antibody production and associated T-cell immunity in a cohort of 200 high-risk infants. Parallel antibody studies tracked responses against a broader panel of inhalant and dietary allergens including peanut. RESULTS: HDM-induced T(H)2 responses in PBMC from 6 months onward, particularly IL-4 and IL-5, correlated increasingly strongly with sensitization outcomes at 2 years, and a contrasting negative relationship was observed with IFN-gamma response capacity. HDM-induced T-cell responses in cord blood, although common, were unrelated to subsequent sensitization. Transient HDM-IgE (and IgG(4)) production frequently peaked at 6 or 12 months before returning to baseline, which suggests the onset of protective tolerance. This finding contrasted with progressively increasing HDM-IgE titers in children sensitized by 2 years of age. Comparably contrasting patterns were observed in peanut-specific responses in sensitized versus nonsensitized children. CONCLUSION: Priming of T(H)2 responses associated with persistent HDM-IgE production occurs entirely postnatally, as HDM reactivity in cord blood seems nonspecific and is unrelated to subsequent development of allergen-specific T(H)2 memory or IgE. CLINICAL IMPLICATIONS: These findings question the scientific basis for existing recommendations for allergen avoidance by high-risk women during pregnancy.


Subject(s)
Allergens/immunology , Environmental Exposure/adverse effects , Hypersensitivity/immunology , Immune System/enzymology , Prenatal Exposure Delayed Effects/immunology , Animals , Child, Preschool , Female , Fetal Blood/cytology , Fetal Blood/immunology , Humans , Immunoglobulin E/blood , Immunoglobulin G/blood , Infant , Infant, Newborn , Interferon-gamma/immunology , Interleukin-4/immunology , Interleukin-5/immunology , Leukocytes, Mononuclear/immunology , Pregnancy , Pyroglyphidae/immunology , Risk Factors , Th2 Cells/immunology
3.
Vaccine ; 25(10): 1764-70, 2007 Feb 26.
Article in English | MEDLINE | ID: mdl-17224218

ABSTRACT

This study compared the potency and immunomodulatory effects of measles mumps rubella (MMR) vaccine given to infants alone or in combination with varicella (MMR and V). In an additional group, MMR vaccination was delayed 42 days to permit analysis of potential effects on underlying maturation of systemic immune functions. Assessment of immunity to the vaccines indicated consistent antibody production coupled with mixed Th1/Th2 memory, and no significant differences between vaccine groups or to the group who had their MMR vaccination delayed. Parallel analyses of cytokine responses to phytohaemagglutinin and tetanus toxoid did not detect any "bystander" effects of the vaccines on systemic immunity.


Subject(s)
Chickenpox Vaccine/immunology , Chickenpox/prevention & control , Measles-Mumps-Rubella Vaccine/immunology , Measles/prevention & control , Mumps/prevention & control , Rubella/prevention & control , Antibodies, Viral/blood , Chickenpox/immunology , Female , Humans , Infant , Interferon-gamma/biosynthesis , Interleukin-13/biosynthesis , Interleukin-5/biosynthesis , Male , Measles/immunology , Mumps/immunology , Rubella/immunology , T-Lymphocytes/immunology , Vaccines, Combined/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...